HT
TEVA icon

HAP Trading’s Teva Pharmaceuticals TEVA Stock Holding History

HAP Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,400
Closed -$3.1K – 1188
2023
Q3 		$3.1K Sell
12,400
-22,000
-64% -$205K ﹤0.01% 911
2023
Q2 		$10.5K Buy
+34,400
New +$279K ﹤0.01% 813
2023
Q1 		– Sell
-88,700
Closed -$21K – 1656
2022
Q4 		$21K Buy
88,700
+14,500
+20% +$127K ﹤0.01% 950
2022
Q3 		$9K Buy
74,200
+21,700
+41% +$192K ﹤0.01% 1355
2022
Q2 		$5K Buy
52,500
+37,200
+243% +$324K ﹤0.01% 1634
2022
Q1 		$8K Sell
15,300
-53,600
-78% -$447K ﹤0.01% 1850
2021
Q4 		$6K Sell
68,900
-46,600
-40% -$421K ﹤0.01% 2197
2021
Q3 		$27K Buy
115,500
+34,600
+43% +$324K ﹤0.01% 1719
2021
Q2 		$11K Buy
+80,900
New +$856K ﹤0.01% 1979
2021
Q1 		– Sell
-372,300
Closed -$109K – 2354
2020
Q4 		$109K Buy
+372,300
New +$3.57M ﹤0.01% 1134
2020
Q3 		– Sell
-122,800
Closed -$173K – 1883
2020
Q2 		$173K Buy
+122,800
New +$1.39M 0.01% 721
2019
Q4 		– Sell
-601,600
Closed -$70K – 1475
2019
Q3 		$70K Buy
601,600
+425,600
+242% +$3.26M 0.01% 684
2019
Q2 		$34K Sell
176,000
-156,100
-47% -$1.88M ﹤0.01% 800
2019
Q1 		$65K Buy
332,100
+152,300
+85% +$2.69M 0.01% 621
2018
Q4 		$42K Sell
179,800
-44,200
-20% -$906K ﹤0.01% 780
2018
Q3 		$137K Buy
224,000
+29,300
+15% +$680K 0.01% 505
2018
Q2 		$298K Buy
194,700
+138,500
+246% +$2.82M 0.01% 403
2018
Q1 		$45K Sell
56,200
-30,300
-35% -$592K ﹤0.01% 660
2017
Q4 		$91K Buy
86,500
+24,800
+40% +$373K ﹤0.01% 599
2017
Q3 		$33K Buy
+61,700
New +$1.39M ﹤0.01% 705
2017
Q1 		– Sell
-17,400
Closed -$8K – 1247
2016
Q4 		$8K Buy
17,400
+7,300
+72% +$291K ﹤0.01% 868
2016
Q3 		$1K Sell
10,100
-281,500
-97% -$14.7M ﹤0.01% 1089
2016
Q2 		$77K Buy
+291,600
New +$15.5M ﹤0.01% 549
2016
Q1 		– Sell
-217,700
Closed -$56K – 1044
2015
Q4 		$56K Buy
217,700
+90,800
+72% +$5.61M ﹤0.01% 624
2015
Q3 		$33K Buy
126,900
+33,600
+36% +$2.18M ﹤0.01% 752
2015
Q2 		$59K Buy
+93,300
New +$5.76M ﹤0.01% 636
2015
Q1 		– Sell
-2,596,000
Closed -$482K – 1203
2014
Q4 		$482K Sell
2,596,000
-122,200
-4% -$6.81M 0.02% 455
2014
Q3 		$1.36M Buy
2,718,200
+218,200
+9% +$11.6M 0.05% 299
2014
Q2 		$1.93M Buy
+2,500,000
New +$128M 0.07% 200
2014
Q1 		– Sell
-179,000
Closed -$152K – 1361
2013
Q4 		$152K Buy
+179,000
New +$7.05M ﹤0.01% 756

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

HAP Trading's TEVA Position: Q3 2025 in Review

HAP Trading opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2025: 14,492 shares worth $293K. The stake represents 0.02% of the portfolio and ranks #341 among its holdings. This is a return to the name: HAP Trading previously reported a position in TEVA as recently as Q4 2023.

HAP Trading first reported a position in TEVA in Q2 2013 and has held it in 31 quarters since. The position peaked at $129M in Q4 2014. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • HAP Trading held 14,492 shares of Teva Pharmaceuticals worth $293K as of Q3 2025.
  • Teva Pharmaceuticals was a new HAP Trading position in Q3 2025.
  • Teva Pharmaceuticals made up 0.02% of HAP Trading's portfolio in Q3 2025, its #341 holding.
  • HAP Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 31 quarters since.
  • HAP Trading's Teva Pharmaceuticals position peaked at $129M in Q4 2014.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.